You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PVCT Award Disclosure
Pershing Edward · SEC Form 4 · Filed Jul 2, 2026
Award
Calculated transaction value
$0
Pershing Edward CEO
PVCT
Transaction date
Jun 30, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 2 days later
PVCT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series D-1 Convertible Preferred Stock on Common Stock
- Quantity / price
- 45,860 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-031718
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. PVCT Current | Award | Jun 30, 2026 | $0 |